Accendra Health ACH Income Statement (2009-2026)

NYSE ACH
$1.08 +0.00 (+0.47%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

Accendra Health Quarterly Income Statement

Periods 69 quarters
Latest Jun 2026

Accendra Health reported revenue of $613.23M and net income of -$89.07M for the quarter ended Jun 2026, down 10.1% year over year. This income statement covers 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
2,502.18M2,467.15M2,406.95M2,500.01M2,497.40M2,551.11M2,522.85M2,563.23M2,591.74M-5125.24M2,612.68M660.40M686.85M695.02M673.88M681.92M697.26M708.97M627.78M613.23M
Cost of RevenueCost of Rev
2,173.34M2,125.57M2,033.50M1,967.51M1,984.12M2,143.99M2,025.54M2,043.79M2,053.24M-4787.03M2,077.15M344.37M355.07M362.03M354.64M357.31M375.07M385.71M349.75M349.83M
Gross Profit
328.84M341.57M373.45M532.50M513.28M407.12M497.31M519.43M538.50M569.92M535.53M544.15M559.71M579.77M526.01M324.60M322.20M323.26M278.03M263.41M
Operating items
Selling, General & AdministrativeSG&A
262.46M227.81M269.47M421.93M430.96M432.47M448.72M455.03M452.58M-354.68M477.61M269.92M272.32M269.89M262.37M267.85M265.84M271.50M255.23M243.56M
Restructuring CostsRestructuring
6.38M21.81M42.13M37.28M21.22M26.34M22.19M29.00M30.22M-0.02M27.36M15.43M14.86M18.94M23.46M13.92M29.23M29.23M29.23M29.23M
Other Operating ExpensesOther Opex
2.87M1.18M0.90M3.00M1.12M0.23M-0.92M-2.40M-1.68M-1.94M-0.55M-5.26M-15.73M8.23M-2.64M439.86M375.73M387.33M326.20M375.60M
Operating ExpensesOpex
268.84M249.62M311.61M459.20M452.17M458.81M470.91M484.03M482.80M-354.70M504.97M643.48M655.77M967.72M654.09M721.63M670.79M688.06M610.65M648.38M
Operating IncomeOp. Inc
62.88M62.02M61.06M75.08M60.25M-53.48M9.81M10.84M23.84M88.74M9.70M16.92M31.08M-272.70M19.79M-39.71M26.47M20.91M17.12M-35.15M
EBIT
62.88M62.02M61.06M75.08M60.25M-53.48M9.81M10.84M23.84M88.74M9.70M16.92M31.08M-272.70M19.79M-39.71M26.47M20.91M17.12M-35.15M
Non-operating items
Non Operating Interest Expenses
11.57M11.31M12.02M35.84M39.87M41.16M42.20M40.73M38.13M-4.28M35.66M25.59M28.95M27.62M24.21M26.01M29.03M27.93M32.35M
Interest & Investment IncomeInt & Inv Inc
-26.01M-34.54M
Other Non Operating IncomeOther Non Op Inc.
Non Operating IncomeNon Op. Inc.
-0.80M-0.80M-0.78M-0.78M-0.78M-0.78M-1.39M-1.07M3.30M-2.04M-1.15M-0.82M-1.17M-1.72M-0.97M-0.94M-1.08M-0.95M-1.02M-0.64M
Net income details
EBT
50.50M49.92M48.26M38.46M19.59M-77.78M-33.78M-30.96M-10.98M90.99M-27.11M-9.48M0.96M-304.03M-5.40M-84.95M-3.63M-10.10M-16.25M-87.63M
Tax ProvisionsTaxes
6.38M37.68M8.98M9.86M7.10M-11.07M-9.36M-2.72M-4.56M29.00M-5.23M-2.74M-0.30M-60.30M-1.59M-1.13M1.97M-20.67M-9.78M1.44M
Profit After TaxPAT
44.13M41.98M39.28M28.60M12.50M-57.99M-24.42M-28.24M-6.43M17.78M-21.89M-31.91M-12.77M-296.12M-24.98M-869.06M-150.28M-56.33M-6.47M-89.07M
Income from Continuing OperationsIncome (Continuing)
44.13M12.24M39.28M28.60M12.50M-66.70M-24.42M-28.24M-6.43M61.99M-21.89M-6.74M1.26M-243.73M-3.81M-83.82M-5.61M10.57M-6.47M-89.07M
Income from Discontinued OperationsIncome (Discontinued)
-25.17M-14.03M35.74M-21.17M-785.24M-144.67M-46.88M
Consolidated Net IncomeConsol Net Inc.
44.13M12.24M39.28M28.60M12.50M-66.70M-24.42M-28.24M-6.43M61.99M-21.89M-31.91M-12.77M-207.99M-24.98M-869.06M-150.28M-36.31M-6.47M-89.07M
Income towards Parent CompanyParent Net Inc
44.13M12.24M39.28M28.60M12.50M-66.70M-24.42M-28.24M-6.43M61.99M-21.89M-31.91M-12.77M-207.99M-24.98M-869.06M-150.28M-36.31M-6.47M-89.07M
Net Income towards Common StockholdersNet Income
44.13M12.24M39.28M28.60M12.50M-66.70M-24.42M-28.24M-6.43M61.99M-21.89M-31.91M-12.77M-207.99M-24.98M-869.06M-150.28M-36.31M-6.47M-89.07M
Additional items
EPS (Basic)
0.600.170.530.380.17-0.90-0.32-0.37-0.080.82-0.29-0.42-0.17-2.71-0.32-11.30-1.94-0.47-0.08-1.16
EPS (Diluted)
0.580.160.520.370.16-0.88-0.32-0.37-0.080.82-0.29-0.42-0.17-2.71-0.32-11.30-1.94-0.47-0.08-1.16
Shares Outstanding
73.22M72.74M73.64M74.71M74.91M74.50M75.18M75.80M76.20M75.78M76.32M76.73M77.09M76.74M77.27M76.94M77.29M76.90M76.43M76.69M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
75.96M75.49M76.02M76.30M76.42M76.22M75.18M75.80M76.20M75.78M76.32M76.73M77.09M76.74M77.27M76.94M77.29M76.90M76.43M76.69M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
75.43M75.43M76.09M76.17M76.22M76.28M76.20M76.44M76.50M76.55M76.45M77.05M77.06M77.20M77.22M77.20M77.30M76.39M76.58M76.91M
EBITDA
62.88M62.02M61.06M75.08M60.25M-53.48M9.81M10.84M23.84M88.74M9.70M16.92M31.08M-272.70M19.79M-39.71M26.47M20.91M17.12M-35.15M
Interest ExpensesInt Expense
11.57M11.31M12.02M35.84M39.87M41.16M42.20M40.73M38.13M-4.28M35.66M25.59M28.95M27.62M24.21M26.01M29.03M27.93M32.35M
Tax Rate
12.62%75.48%18.60%25.63%36.22%14.24%27.71%8.79%41.50%31.87%19.28%28.90%-31.63%19.83%29.42%1.33%-54.25%204.66%60.19%-1.65%